Maze Therapeutics (NASDAQ:MAZE) is advancing a genetics-driven approach to drug development, using human genetic analyses to identify gene variants linked to disease and then applying those insights ...

The company said hackers downloaded “a limited number of files” after breaking into an employee’s account. The hacking group ...

Instead, Vance’s position suggested a more profound rupture in the trans-Atlantic relationship, one where the U.S.’s ...

Spain's construction market, growing at a 3.9% annual rate, offers opportunities in residential, commercial, and industrial sectors. Key drivers include industrialized methods for affordable housing, ...

ServiceNow Inc. is expanding into the realm of “generative business intelligence” through the acquisition of an Israeli ...

Kyvos, the industry-leading semantic layer for AI and BI, today announced the launch of its integration with Claude Cowork, ...

The growth of the Data Analysis Software Market is primarily driven by the exponential rise in structured and unstructured ...

The MSCI Asia Pacific Index rose 0.4% to an all-time high. The gauge is set for its strongest three-day gain in a month ...

Amazon’s $200 billion allocation is 52% greater than last year and surpasses the combined spending of Google and Microsoft in ...